Financials
- Market Capitalization 22.8 M
- Employee 1
- Founded N/A
- CEO N/A
- Website www.therapeuticsmd.com
- Headquarter Nevada, United States
- FIGI BBG000LKB954
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4539 | CPHI China Pharma Holdings, Inc. Common Stock | 0.61 USD | +1.67% | -10.29% | -19.74% | -7.73% | 24.72 M USD | ||
| 4554 | AYTU Aytu BioPharma, Inc. - Common Stock | 2.20 USD | +0.92% | +0.46% | 0.00% | +1.38% | 23.61 M USD | ||
| 4576 | RMTI Rockwell Medical, Inc. - Common Stock | 5.63 USD | -0.71% | -4.74% | +753.03% | +416.51% | 22.22 M USD | ||
| 4636 | AKAN Akanda Corp. - Common Shares | 9.48 USD | -1.04% | -16.99% | -46.29% | +629.23% | 18.80 M USD |
Frequently asked questions about TherapeuticsMD, Inc. - Common Stock
What is the TherapeuticsMD, Inc. - Common Stock stock price today?
The current price of TherapeuticsMD, Inc. - Common Stock (TXMD) is 1.97. Over the past 24 hours, the stock has changed by 0.00%. Follow the TXMD chart for real-time price dynamics.
What is the stock ticker of TherapeuticsMD, Inc. - Common Stock?
TherapeuticsMD, Inc. - Common Stock trades under the ticker TXMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TherapeuticsMD, Inc. - Common Stock stock going up?
TXMD has changed by -0.51% over the last week, -13.97% over the last month, and +71.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TherapeuticsMD, Inc. - Common Stock net income for the last quarter?
TherapeuticsMD, Inc. - Common Stock reported net income of 95 K for the last quarter. The previous quarter showed -619 K, which means net income changed by +115.35%.
How many employees does TherapeuticsMD, Inc. - Common Stock have?
As of the latest available data, TherapeuticsMD, Inc. - Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
What is TherapeuticsMD, Inc. - Common Stock EBITDA?
TherapeuticsMD, Inc. - Common Stock EBITDA is -629 K, and its EBITDA margin is -86.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TherapeuticsMD, Inc. - Common Stock stock?
You can buy TherapeuticsMD, Inc. - Common Stock (TXMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TherapeuticsMD, Inc. - Common Stock stock?
Investing in TherapeuticsMD, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TXMD chart and related analysis on metatrader.com as part of your research.